Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IGI Enters Development and Commercialization Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

IGI Enters Development and Commercialization Pact

Files ANDA for generic topical with global partner

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

IGI Laboratories has entered a license, development, supply and marketing agreement with a large, global pharmaceutical company, to develop and manufacture a generic topical drug product developed at IGI, which will be licensed, marketed and distributed in the U.S. by its partner and/or its subsidiaries.
 
IGI has filed the ANDA associated with the product is eligible to receive milestones related to the filing and approval. IGI will also receive a share of the profits following approval and commercialization.
 
Jason Grenfell-Gardner, president and chief executive officer of IGI, said, “This strategic partnership provides IGI with an opportunity to collaborate with an established generic pharmaceutical drug manufacturer.  This agreement will provide IGI with some liquidity in the near future which will help us accelerate our generic pharmaceutical research and development efforts in 2014.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics